SCOPUS 정보 검색 플랫폼

Nature Reviews Neurology

Volumn 7, Issue 8, 2011, Pages 425-427

Multiple sclerosis: Cladribine-a contentious therapeutic contender for MS

(1) Hohlfeld, Reinhard a

a LUDWIG MAXIMILIANS UNIVERSITY (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; BG 00012; CLADRIBINE; FINGOLIMOD; FUMARIC ACID DERIVATIVE; LAQUINIMOD; PLACEBO; TERIFLUNOMIDE; UNCLASSIFIED DRUG;

ADD ON THERAPY; CLINICAL EFFECTIVENESS; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG APPROVAL; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; DRUG MARKETING; DRUG MEGADOSE; DRUG SAFETY; HUMAN; LONG TERM CARE; LOW DRUG DOSE; MAINTENANCE THERAPY; MULTIPLE CYCLE TREATMENT; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION;

CLADRIBINE; CLINICAL TRIALS AS TOPIC; DEVICE APPROVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROPYLENE GLYCOLS; SPHINGOSINE;

EID: 80051546923 PISSN: 17594758 EISSN: 17594766 Source Type: Journal
DOI: 10.1038/nrneurol.2011.105 Document Type: Review

Times cited : (3)

References (6)

1
- 76149093586
- A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis
- Kappos, L. et al. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. N. Engl. J. Med. 362, 387-401 (2010).
- (2010) N. Engl. J. Med. , vol.362 , pp. 387-401
- Kappos, L.¹

2
- 76149140914
- Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis
- Cohen, J. A. et al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. N. Engl. J. Med. 362, 402-415 (2010).
- (2010) N. Engl. J. Med. , vol.362 , pp. 402-415
- Cohen, J.A.¹

3
- 76149083915
- A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis
- Giovannoni, G. et al. A placebo-controlled trial of oral cladribine for relapsing multiple sclerosis. N. Engl. J. Med. 362, 416-426 (2010).
- (2010) N. Engl. J. Med. , vol.362 , pp. 416-426
- Giovannoni, G.¹

4
- 84857037627
- Merck Serono: Regulatory update on cladribine tablets
- [online]
- Merck Serono. Merck Serono: Regulatory update on cladribine tablets. Merck Serono [online], http://www.merckserono.com/corp.merckserono-2011/en/ images/20110622-en-tcm1494-76074.pdf (2011).
- (2011) Merck Serono
- Merck, S.¹

5
- 79952735730
- Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: A post-hoc and subgroup analysis
- Giovannoni, G. et al. Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: A post-hoc and subgroup analysis. Lancet Neurol. 10, 329-337 (2011).
- (2011) Lancet Neurol. , vol.10 , pp. 329-337
- Giovannoni, G.¹

6
- 78649826782
- Oral therapies for multiple sclerosis: A review of agents in phase III development or recently approved
- Gold, R. Oral therapies for multiple sclerosis: A review of agents in phase III development or recently approved. CNS Drugs 25, 37-52 (2011).
- (2011) CNS Drugs , vol.25 , pp. 37-52
- Gold, R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.